{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000358","form_type":"8-K","ticker":"CURX","cik":"0002025942","company_name":"Curanex Pharmaceuticals Inc","filed_at":"2026-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.025985+00:00","generated_at":"2026-05-16T11:44:33.668007+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Curanex CFO Haiyan Yang resigns; Wanjun Zhang appointed effective Jan 1, 2026","bullets":["Haiyan Yang resigned as CFO and Treasurer effective Dec 31, 2025; no disagreement cited.","Wanjun Zhang appointed as CFO and Treasurer effective Jan 1, 2026.","Zhang has 20+ years experience; previously finance director at Perfect World (PWRD).","Compensation: $20,000 per year under consulting agreement; independent contractor."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000358","json":"https://secwatch.observer/filing/0001493152-26-000358.json","markdown":"https://secwatch.observer/filing/0001493152-26-000358.md","text":"https://secwatch.observer/filing/0001493152-26-000358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2025942/000149315226000358/0001493152-26-000358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2025942/000149315226000358/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:44:33.668007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}